Solange Peters, MD, PhD, is full professor and chair of medical oncology as well as the thoracic malignancies programme in the department of oncology at the University Hospital of Lausanne, Switzerland. She received both her doctorate in medicine and PhD from the University Hospital of Lausanne, Switzerland. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, Professor Peters has specialized in thoracic tumors, lung cancer, and pleural tumors. Professor Peters is currently in charge of teaching and patient care in the area of thoracic malignancies in the department of oncology of Lausanne University, where she is building a translational program in collaboration with the Swiss Federal Institute of Technology in Lausanne and the Ludwig Institute. Professor Peters' main fields of interest are new biomarkers discovery and validation in preclinical and clinical settings, multimodality strategies for locally advanced non-small cell lung cancer (NSCLC), as well as cancer immunotherapy. Professor Peters is active in the educational programs of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC). She is the past-Chair of ESMO Women for Oncology Committee, and she is the youngest ESMO President ever, for a mandate in 2020-2022. She was also a member of the IASLC board of directors, and vice president of the Swiss Group for Clinical Cancer Research lung group.